Wang Y, Long H, Zhou Q, Bo T, Zheng J. PLSNet: Position-aware GCN-based autism spectrum disorder diagnosis via FC learning and ROIs sifting.
Comput Biol Med 2023;
163:107184. [PMID:
37356292 DOI:
10.1016/j.compbiomed.2023.107184]
[Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2022] [Revised: 05/25/2023] [Accepted: 06/13/2023] [Indexed: 06/27/2023]
Abstract
Brain function connectivity, derived from functional magnetic resonance imaging (fMRI), has enjoyed high popularity in the studies of Autism Spectrum Disorder (ASD) diagnosis. Albeit rapid progress has been made, most studies still suffer from several knotty issues: (1) the hardship of modeling the sophisticated brain neuronal connectivity; (2) the mismatch of identically graph node setup to the variations of different brain regions; (3) the dimensionality explosion resulted from excessive voxels in each fMRI sample; (4) the poor interpretability giving rise to unpersuasive diagnosis. To ameliorate these issues, we propose a position-aware graph-convolution-network-based model, namely PLSNet, with superior accuracy and compelling built-in interpretability for ASD diagnosis. Specifically, a time-series encoder is designed for context-rich feature extraction, followed by a function connectivity generator to model the correlation with long range dependencies. In addition, to discriminate the brain nodes with different locations, the position embedding technique is adopted, giving a unique identity to each graph region. We then embed a rarefying method to sift the salient nodes during message diffusion, which would also benefit the reduction of the dimensionality complexity. Extensive experiments conducted on Autism Brain Imaging Data Exchange demonstrate that our PLSNet achieves state-of-the-art performance. Notably, on CC200 atlas, PLSNet reaches an accuracy of 76.4% and a specificity of 78.6%, overwhelming the previous state-of-the-art with 2.5% and 6.5% under five-fold cross-validation policy. Moreover, the most salient brain regions predicted by PLSNet are closely consistent with the theoretical knowledge in the medical domain, providing potential biomarkers for ASD clinical diagnosis. Our code is available at https://github.com/CodeGoat24/PLSNet.
Collapse